Sigilon Therapeutics Inc (SGTX) Financials
$22.47
$0.00 (0.00%)As on 18-Aug-2023 09:30EDT
Market cap
$56 Mln
Revenue (TTM)
$18 Mln
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
17.65
|
12.94
|
9.60
|
13.37
|
14.16
|
4.64
|
|
|
|
|
|
|
Cost of Revenue
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Gross Profit
|
17.65
|
12.94
|
9.60
|
13.37
|
14.16
|
4.64
|
|
|
|
|
|
|
Operating Expenses
|
48.49
|
56.61
|
85.24
|
66.02
|
58.28
|
27.71
|
|
|
|
|
|
|
Operating Profit (EBIT)
|
-30.84
|
-43.67
|
-75.64
|
-52.64
|
-44.12
|
-23.08
|
|
|
|
|
|
|
Other Income
|
0.24
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
-30.24
|
-43.56
|
-77.31
|
-54.61
|
-43.93
|
-22.77
|
|
|
|
|
|
|
Provision for Tax
|
-0.28
|
-0.11
|
0.93
|
0.26
|
0.64
|
0.60
|
|
|
|
|
|
|
Profit after Tax (Net Income)
|
-29.57
|
-43.46
|
-78.24
|
-54.87
|
-44.57
|
-22.77
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
-16.18
|
--
|
-77.31
|
-54.61
|
-43.93
|
-25.76
|
|
|
|
|
|
Liabilities ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
27.45
|
39.14
|
77.16
|
146.16
|
-77.76
|
-36.10
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
2.87
|
17.14
|
32.32
|
31.88
|
127.77
|
74.56
|
|
|
|
|
|
|
Current Liabilities
|
25.25
|
30.99
|
34.89
|
47.02
|
40.38
|
29.20
|
|
|
|
|
|
|
Total Liabilities
|
80.81
|
87.28
|
144.37
|
225.05
|
90.38
|
67.67
|
|
|
|
|
|
Assets ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
10.69
|
12.87
|
17.98
|
20.84
|
13.44
|
3.13
|
|
|
|
|
|
|
Current Assets
|
44.87
|
74.41
|
126.39
|
204.21
|
76.94
|
64.53
|
|
|
|
|
|
|
Total Assets
|
80.81
|
87.28
|
144.37
|
225.05
|
90.38
|
67.67
|
|
|
|
|
|
|
Total Debt*
|
7.39
|
28.06
|
33.50
|
37.06
|
25.05
|
4.96
|
|
|
|
|
|
|
Net Current Assets
|
19.62
|
43.42
|
91.51
|
157.19
|
36.56
|
35.33
|
|
|
|
|
|
Cashflow ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-51.47
|
-78.41
|
-61.65
|
-50.07
|
38.33
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
--
|
-18.06
|
-0.97
|
-1.21
|
-1.65
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-1.61
|
1.55
|
189.40
|
63.24
|
24.23
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Financials Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-3.68
|
-1.34
|
-2.42
|
-4.15
|
-2.12
|
--
|
|
|
|
|
|
|
Cash EPS ($)
|
--
|
-1.30
|
-2.39
|
-4.08
|
-2.09
|
--
|
|
|
|
|
|
|
Adjusted Book Value ($)
|
--
|
1.21
|
2.39
|
11.05
|
--
|
--
|
|
|
|
|
|
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share ($)
|
--
|
-1.59
|
-2.43
|
-4.66
|
-2.38
|
--
|
|
|
|
|
|
|
Free Cash Flow per Share ($)
|
--
|
-1.60
|
-2.48
|
-4.73
|
-2.44
|
--
|
|
|
|
|
|
Profitability Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-48.86
|
-53.24
|
-84.08
|
106.31
|
--
|
|
|
|
|
|
|
ROE (%)
|
-88.83
|
-74.73
|
-70.07
|
-160.44
|
78.29
|
--
|
|
|
|
|
|
|
ROA (%)
|
-26.70
|
-37.52
|
-42.36
|
-34.79
|
-56.40
|
--
|
|
|
|
|
|
|
EBIT Margin (%)
|
-171.75
|
-337.35
|
-787.96
|
-393.61
|
-311.71
|
-484.32
|
|
|
|
|
|
|
Net Margin (%)
|
-165.28
|
-335.72
|
-815.04
|
-410.25
|
-314.86
|
-490.94
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
0.00
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
76.81
|
0.35
|
-0.28
|
-0.06
|
2.05
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
53.14
|
42.27
|
-43.68
|
-19.31
|
-96.47
|
--
|
|
|
|
|
|
|
Net Profit Growth (%)
|
55.73
|
44.46
|
-42.59
|
-23.11
|
-95.78
|
--
|
|
|
|
|
|
|
EPS Growth (%)
|
61.73
|
0.45
|
0.42
|
-0.96
|
--
|
--
|
|
|
|
|
|
|
Book Value Growth (%)
|
586.09
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Valuation Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-0.26
|
-1.14
|
-11.58
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
0.25
|
0.29
|
1.16
|
4.35
|
--
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
0.71
|
0.73
|
0.01
|
-8.97
|
--
|
--
|
|
|
|
|
|
|
Close Price ($)
|
22.51
|
4.55
|
35.88
|
624.39
|
--
|
--
|
|
|
|
|
|
|
High Price ($)
|
28.00
|
40.43
|
668.46
|
706.12
|
--
|
--
|
|
|
|
|
|
|
Low Price ($)
|
3.77
|
3.77
|
32.24
|
0.11
|
--
|
--
|
|
|
|
|
|
|
Market Cap ($ Cr)
|
56.22
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.72
|
0.43
|
0.25
|
-0.32
|
-0.14
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.16
|
0.28
|
0.08
|
0.04
|
-0.04
|
-0.02
|
|
|
|
|
|
|
Current Ratio
|
1.78
|
2.40
|
3.62
|
4.34
|
1.91
|
2.21
|
|
|
|
|
|
|
Quick Ratio
|
1.77
|
2.39
|
3.62
|
4.34
|
--
|
--
|
|
|
|
|
|
|
Interest Coverage
|
-12.89
|
-19.07
|
-38.05
|
-43.80
|
-67.88
|
-77.71
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
38.85
|
26.72
|
0.61
|
1.32
|
0.96
|
--
|
|
|
|
|
|
|
Asset Turnover
|
0.16
|
0.11
|
0.05
|
0.08
|
0.18
|
--
|
|
|
|
|
|
|
Receivable days
|
--
|
49.62
|
4.49
|
4.27
|
1.75
|
--
|
|
|
|
|
|
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Payable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
